OQS
AVNS icon

Occudo Quantitative Strategies’s Avanos Medical AVNS Stock Holding History

Occudo Quantitative Strategies’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-50,220
Closed -$615K – 671
2025
Q2 		$615K Sell
50,220
-440
-0.9% -$5.53K 0.07% 324
2025
Q1 		$707K Buy
50,660
+20,214
+66% +$316K 0.09% 301
2024
Q4 		$485K Buy
+30,446
New +$603K 0.09% 319
2022
Q4 		– Sell
-35,901
Closed -$782K – 958
2022
Q3 		$782K Buy
35,901
+27,064
+306% +$707K 0.06% 508
2022
Q2 		$242K Sell
8,837
-6,058
-41% -$174K 0.02% 853
2022
Q1 		$499K Sell
14,895
-12,810
-46% -$413K 0.04% 652
2021
Q4 		$961K Buy
27,705
+433
+2% +$14K 0.09% 372
2021
Q3 		$851K Buy
27,272
+10,397
+62% +$353K 0.1% 353
2021
Q2 		$614K Buy
+16,875
New +$698K 0.09% 356

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Occudo Quantitative Strategies's AVNS Position: Q3 2025 in Review

Occudo Quantitative Strategies sold out of Avanos Medical (AVNS) in Q3 2025, closing a stake of 50,220 shares — an estimated $615K sold.

Occudo Quantitative Strategies first reported a position in AVNS in Q2 2021 and held it in 9 quarters. The position peaked at $961K in Q4 2021. 276 funds tracked by Wall St. Rank hold AVNS as of Q3 2025.

  • Occudo Quantitative Strategies reported no remaining Avanos Medical position as of Q3 2025 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 50,220 Avanos Medical shares in Q3 2025, an estimated $615K.
  • Occudo Quantitative Strategies first reported a position in Avanos Medical in Q2 2021 and held it in 9 quarters.
  • Occudo Quantitative Strategies's Avanos Medical position peaked at $961K in Q4 2021.
  • 276 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.